Search Results for: TP53

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
UBE2K ubiquitin conjugating enzyme E2 K
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Negative regulators of DDX58/IFIH1 signaling
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2L3 ubiquitin conjugating enzyme E2 L3
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Antigen processing: Ubiquitination & Proteasome degradation
WWOX WW domain containing oxidoreductase
  • Nuclear signaling by ERBB4
  • Negative regulation of activity of TFAP2 (AP-2) family transcription factors
  • Activation of the TFAP2 (AP-2) family of transcription factors
YBX1 Y-box binding protein 1
  • mRNA Splicing - Major Pathway
  • mRNA Splicing - Minor Pathway
  • Noncanonical activation of NOTCH3
ACKR3 atypical chemokine receptor 3
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
ARID1A AT-rich interaction domain 1A
  • RMTs methylate histone arginines
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
ATXN3 ataxin 3
  • Josephin domain DUBs
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
BAK1 BCL2 antagonist/killer 1
  • Activation and oligomerization of BAK protein
  • Release of apoptotic factors from the mitochondria
CDC14A cell division cycle 14A
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • MAPK6/MAPK4 signaling
CENPX centromere protein X
  • Deposition of new CENPA-containing nucleosomes at the centromere
  • Fanconi Anemia Pathway
COP1 COP1 E3 ubiquitin ligase
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Neddylation
DHCR24 24-dehydrocholesterol reductase
  • Cholesterol biosynthesis via desmosterol
  • Cholesterol biosynthesis via lathosterol
  • Desmosterolosis
DTL denticleless E3 ubiquitin protein ligase homolog
  • Recognition of DNA damage by PCNA-containing replication complex
  • Neddylation
EFEMP2 EGF containing fibulin extracellular matrix protein 2
  • Molecules associated with elastic fibres
  • Molecules associated with elastic fibres
  • Cutis laxa, including: Autosomal dominant cutis laxa (ADCL); Autosomal recessive cutis laxa I (ARCL1); Autosomal recessive cutis laxa II (ARCL2); X-linked recessive cutis laxa (XRCL); Wrinkly skin syndrome
EGLN3 egl-9 family hypoxia inducible factor 3
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Ascorbic acid
  • Roxadustat
EIF2AK2 eukaryotic translation initiation factor 2 alpha kinase 2
  • ISG15 antiviral mechanism
  • Inhibition of PKR
  • Fostamatinib
ELL3 elongation factor for RNA polymerase II 3
  • RNA polymerase II transcribes snRNA genes
  • RNA polymerase II transcribes snRNA genes
FBXO11 F-box protein 11
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
GADD45A growth arrest and DNA damage inducible alpha
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • FOXO-mediated transcription of cell cycle genes
GSTM4 glutathione S-transferase mu 4
  • Glutathione conjugation
  • Biosynthesis of maresin conjugates in tissue regeneration (MCTR)
  • Glutathione
  • Glutathione sulfonic acid
  • S-octylglutathione
  • Glutathione disulfide
  • gamma-Glutamyl[S-(2-iodobenzyl)cysteinyl]glycine
  • 1-Hydroxy-2-S-glutathionyl-3-para-nitrophenoxy-propane
  • S-Hexylglutathione

Page 15 out of 25 pages